Compositions and methods for treating mammals with modified alginates and modified pectins
A modified alginate and/or modified pectin composition and method for preventing and/or treating diseases and/or conditions caused by circulating agents such as poisonous heavy metals, environmental toxins, calcium and cholesterol, is provided. The composition includes a modified alginate having a molecular weight of no more than 40,000 daltons and/or a modified pectin having a molecular weight of no more than 40,000 daltons. The method involves orally or intravenously administering the modified alginate and/or modified pectin composition, alone or with excipient.
1. A method of treating a condition or disease mediated by an agent selected from the group consisting of a poisonous metal, an environmental toxin and calcium circulating in the blood, the disease or condition being selected from the group consisting of blood poisoning, arteriosclerosis, atherosclerosis, calcinosis, dermatomytosis, obesity, hypercholesterolima, and diabetes, the method comprising administering to a mammal in need of same an effective amount of alginate comprised of a mixture of polymannuronic acid with galactic linkages at the 1 e– 4 e -di-equatorial position and polyguluronic acid with glycosidic linkages at the 1 a– 4 a -di-axial position having a molecular weight of no more than 40,000 daltons, in an amount to effectively bind said agent.
2. The method of claim 1 , wherein said condition is metal poisoning, and said agent is a poisonous heavy metal.
3. The method of claim 2 , wherein said heavy metal is selected from the group consisting of aluminum, antimony, beryllium, bismuth, mercury, platinum, thallium, thorium, tin, tungsten, uranium, lead, cadmium, arsenic, silver, nickel, radioactive metals and mixtures thereof.
4. The method of claim 3 , wherein administration of said alginate is accompanied by administration of pectin comprised of partially esterified polymers of galacturonic acid having a molecular weight of no more than 40,000 daltons.
5. The method of claim 1 , wherein said alginate is administered orally or intravenously.